Skye Bioscience, Inc. Proceeds from Issuance of Warrants
Skye Bioscience, Inc. (SKYE) reported Proceeds from Issuance of Warrants of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2023-03-31
- Skye Bioscience, Inc. proceeds from issuance of warrants for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Skye Bioscience, Inc. proceeds from issuance of warrants for fiscal 2021 was $7.00M, a 14323.17% increase from fiscal 2020.
- Skye Bioscience, Inc. proceeds from issuance of warrants for fiscal 2020 was $48.53K, a 98.81% decline from fiscal 2019.
- Skye Bioscience, Inc. proceeds from issuance of warrants for fiscal 2019 was $4.08M, a 4033.74% increase from fiscal 2018.
| Period end | Proceeds from Issuance of Warrants 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-12-31 | $7.00M 10-K · filed 2023-03-31 |
| 2020-12-31 | $48.53K 10-K · filed 2022-03-28 |
| 2019-12-31 | $4.08M 10-K · filed 2021-03-02 |
| 2018-12-31 | $98.70K 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |